Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers

Cognitive impairment is frequently reported among anti-phospholipid syndrome (APS) patients as well as anti-phospholipid antibody (aPL) carriers, but it is less studied than other manifestations of this condition. Moreover, the exact prevalence of cognitive impairment in these patients has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Fadi, Naffaa, Mohammad E., Saab, Amir, Putterman, Chaim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870021/
https://www.ncbi.nlm.nih.gov/pubmed/35203985
http://dx.doi.org/10.3390/brainsci12020222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870021/
https://www.ncbi.nlm.nih.gov/pubmed/35203985
http://dx.doi.org/10.3390/brainsci12020222

Ejemplares similares